These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents. Teitelbaum R; Cohen M Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990 [No Abstract] [Full Text] [Related]
4. US courts struggle with new patent infringement standards. Jones P Nat Biotechnol; 2004 Apr; 22(4):461-3. PubMed ID: 15085803 [No Abstract] [Full Text] [Related]
5. Federal court raises the bar for overturning patents. Schubert C Nat Med; 2011 Jul; 17(7):758. PubMed ID: 21738135 [No Abstract] [Full Text] [Related]
6. Pharmaceutical patent life-cycle management after KSR v. Teleflex. Furrow ME Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462 [No Abstract] [Full Text] [Related]
7. Patent infringement. High court asked to rule on what makes an idea new. Malakoff D Science; 2001 Dec; 294(5551):2460-1. PubMed ID: 11752553 [No Abstract] [Full Text] [Related]
10. Patent fight sparks biological warfare in the drug industry. Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662 [No Abstract] [Full Text] [Related]
11. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape. Lu DL; Kowalski TJ; Jarecki-Black J Future Med Chem; 2010 Jan; 2(1):7-9. PubMed ID: 21426040 [No Abstract] [Full Text] [Related]
12. Canadian High Court upholds Glaxo Wellcome AZT patent. AIDS Policy Law; 2002 Dec; 17(22):3. PubMed ID: 12510642 [No Abstract] [Full Text] [Related]
13. Robert Stoll. Interview by Charlotte Harrison. Stoll R Nat Rev Drug Discov; 2009 Dec; 8(12):926. PubMed ID: 19949397 [No Abstract] [Full Text] [Related]